Erratum: Acetyl-11-keto-b-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression (International Journal of Cancer (2011) 129: 1 (23-33) DOI: 10.1002/ijc.25966);Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression

International Journal of Cancer

Volumn 129, Issue 1, 2011, Pages 23-33

  Park, Byoungduck ^a   Sung, Bokyung ^a   Yadav, Vivek R ^a   Cho, Sung Gook ^b   Liu, Mingyao ^b   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

AKBA; CXCL12; CXCR4; metastasis

Indexed keywords

ACETYL 11 OXO BETA BOSWELLIC ACID; BOSWELLIC ACID; CHEMOKINE RECEPTOR CXCR4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS; PANCREAS CANCER; PANCREAS CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 79955468686     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27464     Document Type: Erratum

References (46)

1. Gupta PB, Mani S, Yang J, Hartwell K, Weinberg RA,. The evolving portrait of cancer metastasis. Cold Spring Harb Symp Quant Biol 2005; 70: 291-7. (Pubitemid 44124883)
2. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA,. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-39. (Pubitemid 38798858)
3. Leivonen SK, Kahari VM,. Transforming growth factor-β signaling in cancer invasion and metastasis. Int J Cancer 2007; 121: 2119-24.
4. van Kempen LC, Coussens LM,. MMP9 potentiates pulmonary metastasis formation. Cancer Cell 2002; 2: 251-2. (Pubitemid 41043957)
5. Orosz P, Echtenacher B, Falk W, Ruschoff J, Weber D, Mannel DN,. Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med 1993; 177: 1391-8. (Pubitemid 23117129)
6. Carmeliet P, Jain RK,. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-57.
7. Zeelenberg IS, Ruuls-Van Stalle L, Roos E,. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003; 63: 3833-39. (Pubitemid 36793074)
8. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-6. (Pubitemid 32225831)
9. Taichman RS, Cooper C, Keller ET, Pienta KJ, Taichman NS, McCauley LK,. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002; 62: 1832-7. (Pubitemid 34408510)
10. Porcile C, Bajetto A, Barbero S, Pirani P, Schettini G,. CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line. Ann N Y Acad Sci 2004; 1030: 162-9. (Pubitemid 40378910)
11. Raman D, Baugher PJ, Thu YM, Richmond A,. Role of chemokines in tumor growth. Cancer Lett 2007; 256: 137-65. (Pubitemid 47418345)
12. Syrovets T, Buchele B, Krauss C, Laumonnier Y, Simmet T,. Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-α induction in monocytes by direct interaction with IκB kinases. J Immunol 2005; 174: 498-506. (Pubitemid 40007440)
13. Takada Y, Ichikawa H, Badmaev V, Aggarwal BB,. Acetyl-11-keto-β- boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-κB and NF-κB-regulated gene expression. J Immunol 2006; 176: 3127-40.
14. Liu JJ, Nilsson A, Oredsson S, Badmaev V, Zhao WZ, Duan RD,. Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis 2002; 23: 2087-93. (Pubitemid 36104960)
15. Lu M, Xia L, Hua H, Jing Y,. Acetyl-keto-β-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells. Cancer Res 2008; 68: 1180-6. (Pubitemid 351272237)
16. Zhao W, Entschladen F, Liu H, Niggemann B, Fang Q, Zaenker KS, Han R,. Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. Cancer Detect Prev 2003; 27: 67-75. (Pubitemid 36339419)
17. Liu JJ, Nilsson A, Oredsson S, Badmaev V, Duan RD,. Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int J Mol Med 2002; 10: 501-5.
18. Hostanska K, Daum G, Saller R,. Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro. Anticancer Res 2002; 22: 2853-62. (Pubitemid 36069325)
19. Takada Y, Murakami A, Aggarwal BB,. Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene 2005; 24: 6957-69. (Pubitemid 41509418)
20. Peters AH, Kubicek S, Mechtler K, O'sullivan RJ, Derijck AA, Perez-Burgos L, Kohlmaier A, Opravil S, Tachibana M, Shinkai Y, Martens JH, Jenuwein T,. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell 2003; 12: 1577-89. (Pubitemid 38037024)
21. Maroni P, Bendinelli P, Matteucci E, Desiderio MA,. HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-kappaB. Carcinogenesis 2007; 28: 267-79. (Pubitemid 46321842)
22. Arumugam T, Ramachandran V, Logsdon CD,. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst 2006; 98: 1806-18. (Pubitemid 46017932)
23. Evans DB, Lee JE, Pisters PW, Charnsangavej C, Ellis LM, Chiao PJ, Lenzi R, Abbruzzese JL,. Advances in the diagnosis and treatment of adenocarcinoma of the pancreas. Cancer Treat Res 1997; 90: 109-25.
24. Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Hori T, Fujii N, Imamura M,. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 2000; 6: 3530-5.
25. Day JD, DiGiuseppe JA, Yao C, Lai-Goldman MC, Anderson SM, Goodman SN, Kern SE, Hruban RH,. Immunohistochemical evaluation of HER2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. Hum Pathol 1996; 2: 119-24. (Pubitemid 26049464)
26. Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, Tan M, Zhou X, Xia W, Hortobagyi GN, Yu D, Hung MC,. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004; 6: 459-69. (Pubitemid 39469982)
27. Bhandari D, Trejo J, Benovic JL, Marchese A,. Arrestin-2 interacts with the ubiquitin-protein isopeptide ligase atrophin-interacting protein 4 and mediates endosomal sorting of the chemokine receptor CXCR4. J Biol Chem 2007; 282: 36971-9.
28. Marchesi F, Monti P, Leone BE, Zerbi A, Vecchi A, Piemonti L, Mantovani A, Allavena P,. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4. Cancer Res 2004; 64: 8420-7. (Pubitemid 39491782)
29. Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, Tanaka Y, Washida M, Morikane K, Fukushima Y, Yamori T, Tsuruo T, et al. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner. Cancer Res 2005; 65: 5864-71. (Pubitemid 40911192)
30. Smith MC, Luker KE, Garbow JR, Prior JL, Jackson E, Piwnica-Worms D, Luker GD,. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 2004; 64: 8604-12. (Pubitemid 39552073)
31. Kulbe H, Hagemann T, Szlosarek PW, Balkwill FR, Wilson JL,. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res 2005; 65: 10355-10362. (Pubitemid 41743728)
32. Bachelder RE, Wendt MA, Mercurio AM,. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 2002; 62: 7203-6. (Pubitemid 36025239)
33. Marchese A, Benovic JL,. Agonist- promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem 2001; 276: 45509-12.
34. Staller P, Sulitkova J, Lisztwan J, Moch H, Oakeley EJ, Krek W,. Chemokine receptor CXCR4 down-regulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003; 425: 307-11. (Pubitemid 37158407)
35. Richard CL, Blay J,. Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor γ-dependent manner. Int J Oncol 2007; 30: 1215-22.
36. Kukreja P, Abdel-Mageed AB, Mondal D, Liu K, Agrawal KC,. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Cancer Res 2005; 65: 9891-8. (Pubitemid 41541469)
37. Cabioglu N, Sahin A, Doucet M, Yavuz E, Igci A, O Yildirim E, Aktas E, Bilgic S, Kiran B, Deniz G, Price JE,. Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow. Clin Exp Metastasis 2005; 22: 39-46. (Pubitemid 41185860)
38. Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, Liu M,. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res 2009; 69: 5893-900.
39. Kunnumakkara AB, Nair AS, Sung B, Pandey MK, Aggarwal BB,. Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1. Mol Cancer Res 2009; 7: 118-28.
40. Park YS, Lee JH, Bondar J, Harwalkar JA, Safayhi H, Golubic M,. Cytotoxic action of acetyl-11-keto-beta-boswellic acid (AKBA) on meningioma cells. Planta Med 2002; 68: 397-401. (Pubitemid 34606680)
41. Teicher BA,. Antibody-drug conjugate targets. Curr Cancer Drug Targets 2009; 9: 982-1004.
42. Burger JA, Stewart DJ,. CXCR4 chemokine receptor antagonists: perspectives in SCLC. Expert Opin Investig Drugs 2009; 18: 481-90.
43. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T, Schettini G,. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003; 63: 1969-74. (Pubitemid 36460865)
44. Zhang XF, Wang JF, Matczak E, Proper JA, Groopman JE,. Janus kinase 2 is involved in stromal cell-derived factor-1alpha-induced tyrosine phosphorylation of focal adhesion proteins and migration of hematopoietic progenitor cells. Blood 2001; 97: 3342-8.
45. Petit I, Jin D, Rafii S,. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007; 28: 299-307. (Pubitemid 46963141)
46. Sengupta K, Alluri KV, Satish AR, Mishra S, Golakoti T, Sarma KV, Dey D, Raychaudhuri SP,. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Res Ther 2008; 10: R85.